Market Place
Sourcing Support
GRI Bio to Participate in the Virtual Investor Closing Bell Series
06 Dec 2024 //
GLOBENEWSWIRE
GRI Bio Highlights GRI-0621’s Impact on IPF and Inflammation
21 Nov 2024 //
GLOBENEWSWIRE
GRI Bio Reports Q3 2024 Results, GRI-0621 Data in IPF Study
14 Nov 2024 //
GLOBENEWSWIRE
GRI Bio Raises $13.9 Million In Gross Proceeds In 2024
24 Oct 2024 //
GLOBENEWSWIRE
GRI Bio Announces Exercise of Warrants
21 Oct 2024 //
GLOBENEWSWIRE
GRI Bio Presents On GRI-0621 Inhibiting iNKT In Pulmonary Fibrosis
16 Oct 2024 //
GLOBENEWSWIRE
GRI Bio To Present At 22nd Colloquium on Lung And Airway Fibrosis
07 Oct 2024 //
GLOBENEWSWIRE
GRI Bio Granted Japan Patent For Natural Killer T Cell Modulators
30 Sep 2024 //
GLOBENEWSWIRE
GRI Bio Receives Authorization For Phase 2a Study In Australia
26 Sep 2024 //
GLOBENEWSWIRE
GRI Bio To Participate In Virtual Investor CEO Connect
25 Sep 2024 //
GLOBENEWSWIRE
GRI Bio Participates in Virtual Investor KOL Connect Segment
18 Sep 2024 //
GLOBENEWSWIRE
GRI Bio To Present At H.C. Wainwright Investment Conference
05 Sep 2024 //
GLOBENEWSWIRE
GRI Bio to Present at the 2024 European Respiratory Congress
04 Sep 2024 //
GLOBENEWSWIRE
GRI Bio Reports Q2 2024 Financial Results And Corporate Update
14 Aug 2024 //
GLOBENEWSWIRE
GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series
15 Jul 2024 //
GLOBENEWSWIRE
GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment
11 Jul 2024 //
GLOBENEWSWIRE
GRI Bio Regains Compliance with Nasdaq
08 Jul 2024 //
GLOBENEWSWIRE
GRI Bio Publishes Positive Preclinical Data For GRI-0621 In AJRCCM
02 Jul 2024 //
GLOBENEWSWIRE
GRI Bio to Present at the 8th Annual IPF Summit
01 Jul 2024 //
GLOBENEWSWIRE
GRI Bio Announces Closing of $4.0 Million Public Offering
28 Jun 2024 //
GLOBENEWSWIRE
GRI Bio Announces Pricing of $4 Million Public Offering
27 Jun 2024 //
GLOBENEWSWIRE
GRI Announces Patent Granted for Proprietary NKT Cell Modulators
27 Jun 2024 //
GLOBENEWSWIRE
GRI Bio Announces Reverse Stock Split
14 Jun 2024 //
GLOBENEWSWIRE
GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch Conference
11 Jun 2024 //
GLOBENEWSWIRE
GRI Bio Highlights Positive IPF, SLE Preclinical Data
22 May 2024 //
GLOBENEWSWIRE
GRI Bio Shows Lead IPF Program Reduces Inflammation, Fibrosis
20 May 2024 //
GLOBENEWSWIRE
GRI Bio to Present at Alliance Global Partner`s 2024 Healthcare Company Showcase
14 May 2024 //
GLOBENEWSWIRE
GRI Bio Reports Q1 2024 Results, Corporate Update
13 May 2024 //
GLOBENEWSWIRE
GRI Bio Abstracts at 14th Intl Autoimmunity Congress
29 Apr 2024 //
GLOBENEWSWIRE
GRI Bio Presents at Webull Biotech Investment Webinar
25 Apr 2024 //
GLOBENEWSWIRE
GRI Bio Secures Korea Patent for Natural Killer T Cell Modulator Technology
16 Apr 2024 //
GLOBENEWSWIRE
GRI Announces Abstract Accepted for Presentation at the ATSIC
08 Apr 2024 //
GLOBENEWSWIRE
GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
01 Apr 2024 //
GLOBENEWSWIRE
GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference
28 Mar 2024 //
GLOBENEWSWIRE
GRI Bio Announces Notice of Allowance for Patent Covering Proprietary NKT
14 Mar 2024 //
GLOBENEWSWIRE
GRI Bio Receives MHRA Authorization to Conduct Ph 2a Study Evaluating GRI-0621
04 Mar 2024 //
GLOBENEWSWIRE
GRI Bio Announces Pricing of $5.5 Million Public Offering
02 Feb 2024 //
GLOBENEWSWIRE
GRI Bio Announces Reverse Stock Split
26 Jan 2024 //
GLOBENEWSWIRE
GRI Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating GRI-0621
05 Dec 2023 //
GLOBENEWSWIRE
GRI Bio Announces FDA Clearance of IND for Lead Program GRI-0621
27 Nov 2023 //
GLOBENEWSWIRE
GRI Bio Reports Third Quarter 2023 Financial Results
15 Nov 2023 //
GLOBENEWSWIRE
GRI Bio Presents Data Supporting Innovative Pipeline of NKT Cell Modulators
31 Oct 2023 //
GLOBENEWSWIRE
GRI Bio Presents Data Demonstrating Connection Between NKT Cells & Pathogenesis
19 Oct 2023 //
GLOBENEWSWIRE
GRI Announces Partnership with Respiratory Translational Research Collaboration
17 Oct 2023 //
GLOBENEWSWIRE
GRI Bio to Participate in the Virtual Investor Ask the CEO Conference
11 Oct 2023 //
GLOBENEWSWIRE
GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review
05 Oct 2023 //
GLOBENEWSWIRE
GRI Bio to Present at H.C. Wainwright 25th Annual Global Investment Conference
06 Sep 2023 //
GLOBENEWSWIRE
GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics
23 Aug 2023 //
GLOBENEWSWIRE
GRI Bio Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
GRI Bio Presents Encouraging Data Indicating Oral Administration of GRI-0803
07 Aug 2023 //
GLOBENEWSWIRE
GRI Bio (NASDAQ: GRI) to Present at Benzinga™s Virtual Biotech Conference
03 Aug 2023 //
GLOBENEWSWIRE
GRI Bio to Present at Investor The GRI Opportunity Spotlight Event
24 Jul 2023 //
GLOBENEWSWIRE
GRI Bio to Participate in the Virtual Investor Summer Spotlight Series
05 Jul 2023 //
GLOBENEWSWIRE
GRI Bio (NASDAQ: GRI) Bolsters Patent Portfolio
27 Jun 2023 //
GLOBENEWSWIRE
GRI Bio to Participate in the Healthcare Virtual Conference Presented by Maxim
15 Jun 2023 //
GLOBENEWSWIRE
GRI Bio (NASDAQ: GRI) Announces Corporate Rebranding and Launch of New Website
13 Jun 2023 //
GLOBENEWSWIRE
GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor New to the Street Event
27 Apr 2023 //
GLOBENEWSWIRE
GRI Bio (NASDAQ: GRI) Announces Appointment of Leanne Kelly as CFO
25 Apr 2023 //
GLOBENEWSWIRE
GRI Bio Announces Board of Director Appointments Adding Leadership
24 Apr 2023 //
GLOBENEWSWIRE
Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio
20 Apr 2023 //
GLOBENEWSWIRE
